Creative Medical Technology Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on January 9, 2018, by Creative Medical Technology Holdings, Inc., a Nevada corporation. The report details a corporate governance action taken by stockholders via non-unanimous majority written consent in lieu of a special meeting.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a capital structure amendment and does not contain financial performance data.
Material Changes
Stockholders approved an amendment to the Company's Articles of Incorporation to increase the authorized shares of Common Stock from 600,000,000 to 3,000,000,000. The par value remains $0.001 per share.
- Votes in Favor: 65,844,993 shares (54.88% of voting shares).
- Effective Date: The amendment will become effective upon filing the Certificate of Amendment with the Nevada Secretary of State, approximately 20 days after the definitive information statement is mailed to stockholders.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items beyond the procedural details of the stockholder vote.
Key Facts for Investor Verification
- Verify the final filing date of the Certificate of Amendment with the Nevada Secretary of State to confirm the effective date of the share increase.
- Confirm the total number of outstanding shares to assess the potential dilution impact of the increased authorized share count.
- Review the definitive information statement mailed to stockholders for additional context on the rationale for the amendment.